Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study-Reference-Cited by-同舟云学术

Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study

Published:2018-01-11 Issue:3 Volume:100 Page:247-256
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Li Ji-Wei¹²^ORCID,Li Ya-Jun¹²,Zhong Mei-Zuo³,Liu Xian-Ling⁴,Li Jin¹²^ORCID,Li Kun-Lun¹²,Liu Xi-Yu¹²,Zhou Fang¹²,OuYang Zhou¹²,Sun Zhong-Yi¹²,Huang Li-Jun¹²,He Jun-Qiao¹²,Zhou Hui¹²,Yi Ping-Yong¹²

Affiliation:

1. Department of Lymphoma and Hematology; Hunan Cancer Hospital; Changsha Hunan China

2. The Affiliated Cancer Hospital of Xiangya School of Medicine; Central South University; Changsha Hunan China

3. Department of Oncology; Xiangya Hospital; Central South University; Changsha Hunan China

4. Cancer Center of the Second Xiangya Hospital; Central South University; Changsha Hunan China

Funder

Hunan Provincial Science and Technology Department

Heath and Family Planning Commission of Hunan Province

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13004/fullpdf

Reference50 articles.

1. How I treat NK/T-cell lymphomas;Tse;Blood,2013

2. Distribution of lymphoid neoplasms in China;Sun;Am J Clin Pathol,2012

3. Sequential DICE combined with L-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma;Dong;Leuk Lymphoma,2016

4. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy;Li;Cancer,2011

5. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma;Li;Int J Radiat Oncol Biol Phys,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data;Frontiers in Oncology;2024-07-31

2. Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life;International Journal of Radiation Oncology*Biology*Physics;2023-11

3. Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis;Journal of Hematology;2023-10

4. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07

5. Management of adverse effects associated with pegylated Escherichia coli asparaginase on coagulation in the treatment of patients with NK/T-cell lymphoma;Medicine;2022-03-11